Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection.

Ariel IsraelYotam ShenharIlan GreenEugene MerzonAvivit Golan-CohenAlejandro A Schäffer Eytan Ruppin Shlomo Vinker Eli Magen

Published in: medRxiv : the preprint server for health sciences (2021)

Large scale study display the kinetics of SARS-CoV-2 IgG antibodies present in individuals vaccinated with two doses of mRNA vaccine vs. unvaccinated patients who had recovered from the disease: initial levels of antibody are much higher in vaccinated patients, but decrease faster.

Keyphrases

sars cov
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
respiratory syndrome coronavirus